Company
ChinaYangtze River Pharmaceutical (Group) Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Yangtze River Pharmaceutical (Group) Co., Ltd.. 1 FDA inspection on record, 1 Form 483, last inspected June 28, 2024.
Company Profile
This profile covers Yangtze River Pharmaceutical (Group) Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected June 28, 2024.
Most cited issue areas
- Environmental Monitoring System1 inspection
- Procedures for sterile drug products1 inspection
- Validation lacking for sterile drug products1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 28, 2024 | VAI | Human Drugs · Generic Drug Evaluation | 1245074 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- China NMPA · 5 inspections · last June 1, 2020
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Hefei Yatai Daily-Use Chemical Industry Co., Ltd.
CSPC-NBP Pharmaceutical Co., Ltd.
Shenzhen Senton Science & Technology Co.,Ltd.
ZHEJIANG JINGHUI COSMETICS SHARE CO.,LTD
Nantong Health & Beyond Hygienic Products Inc.
Chenggu Zhenhua Biological Science & Technology Co., Ltd.
Jinhua Jingdi Medical Supplies Co., Ltd.
Jiangxi Sanyuan Pharmaceutical Co., Ltd.
Zhejiang Ayan Biotech Co.,Ltd.
Jilin Shengtong Chemical Co., Ltd.
Company Information
Name
Yangtze River Pharmaceutical (Group) Co., Ltd.
FEI Number
3009173840
Address
China
Country
China
ID: 4758b09d-0a30-4746-b0e0-a55f6d216919